160 filings
Page 2 of 8
8-K
815wuzqu1cduhecuz
9 Nov 23
Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
4:14pm
8-K
0pem1107qohv9ndyxuy1
12 Sep 23
Other Events
4:42pm
8-K
rtm6z
14 Aug 23
Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
4:09pm
8-K
efdrr5o9
28 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
8-K
zg0pzb5qqmr3w8w0h5
30 Jun 23
Departure of Directors or Certain Officers
4:16pm
8-K
1g3i6op
16 Jun 23
Submission of Matters to a Vote of Security Holders
5:44pm
8-K
92eygreb 78w
11 May 23
Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
4:11pm
8-K
tm6xo3w duvwf
14 Apr 23
Departure of Directors or Certain Officers
4:15pm
8-K
ny45oleai1 rjpq
16 Mar 23
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:43pm
8-K
ddvtcxyry 3jh9q00d6a
10 Mar 23
Regulation FD Disclosure
5:17pm
8-K
zhsrz5tg8 c6j
10 Feb 23
Departure of Directors or Certain Officers
4:32pm
8-K
mj26t5
10 Jan 23
Departure of Directors or Certain Officers
4:15pm
8-K
cskvn wm8gw09m2vn5g1
9 Jan 23
Departure of Directors or Certain Officers
5:03pm
8-K
xr2d5o51sfhk 402qpmh
20 Dec 22
Departure of Directors or Certain Officers
4:46pm
8-K
i6041
8 Dec 22
Other Events
8:16am
8-K
ckegzhp6
3 Nov 22
Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
4:06pm
8-K
hxwky85 iz
4 Aug 22
Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:11pm
8-K
tztsq3qo175hels2 7e
18 Jul 22
Departure of Directors or Certain Officers
4:15pm
8-K
upqswf3hf
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
qh9fikxm8h82dk
7 Jun 22
Entry into a Material Definitive Agreement
4:15pm